The concept of the Patient-Centered Medical Home (PCMH) has received plenty of attention, but its foundation is built on understanding who will be the repeat customers. Finding the best yardstick to determine that is the subject of a study published this month by The American Journal of Managed Care.
Best Way to Identify High-Risk Patients Focus of AJMC Study
PLAINSBORO, N.J. — The concept of the Patient-Centered Medical Home (PCMH) has received plenty of attention, but its foundation is built on understanding who will be the repeat customers. Finding the best yardstick to determine that is the subject of a study published this month by The American Journal of Managed Care, led by Lindsey R. Haas, MPH. This retrospective cohort analysis involved patients who were treated by the Employee and Community Health Clinic of the Mayo Clinic in the area of Rochester, Minnesota. The study examined six methods of analyzing risk:
Adjusted Clinical Groups. A method developed by Johns Hopkins involving the presence or absence of specific diagnoses, involves 93 specific categories.
Minnesota Tiering. A product of ACG, involves major conditions.
Hierarchical Condition Categories. Used by the Centers for Medicaid and Medicare Services (CMS) 70 conditions that are assessed for a single risk score. The HCC categories predict the Elder Risk Assessment (ERA) Index, which incorporates age, gender, marital status and prior hospitalization days over the prior 2 years.
Chronic Condition Count. A comorbidity count grouped in to six categories. Comorbidities are considered higher risk factors for costs.
Charlson Comorbidity Index. Originally derived to classify comorbidities affecting 1-year mortality in cancer patients, sums weights for 17 specific conditions.
Hybrid Model. A care coordination patient enrollment process developed in the author’s practice based on combining MN Tiering and the ERA score as a hybrid model.
The authors note that for care coordination to be used effectively, it is important to identify which patients are likely to benefit from it. Prior to the study, there was little evidence exists on which risk-stratification method performed better in predicting hospitalizations, emergency department visits, 30-day readmissions, and high-cost users.
After the analysis, there appeared to be good concordance among the six different instruments in predicting hospitalization. ACG classification was generally better than other models in predicting healthcare utilization. Focusing care coordination efforts within the medical home on patients likely to benefit most requires appropriate identification of the highest-utilizing patients. Click here for study.
CONTACT: Nicole Beagin (609) 716-7777 x 131
www.ajmc.com Follow us on Twitter@AJMC_Journal
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More